Prescription drug · NDA AUTHORIZED GENERIC
benazepril hydrochloride and hydrochlorothiazide NDC 0574-0229
Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet · Oral · Padagis US LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0574-0229-01 | 0057402290100574022901 | 100 TABLET in 1 BOTTLE (0574-0229-01)Marketed from Apr 7, 2019 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- benazepril hydrochloride and hydrochlorothiazide
- Generic name (nonproprietary)
- benazepril hydrochloride and hydrochlorothiazide
- Active ingredients
- Benazepril hydrochloride — 20 mg/1Hydrochlorothiazide — 12.5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Padagis US LLCNDC labeler code 0574
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 020033
- Marketing start
- Marketing end
- Other FDA classes
- Angiotensin-converting Enzyme Inhibitors (Mechanism)Decreased Blood Pressure (Physiologic effect)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
- Identifiers
- Product ID 0574-0229_55072852-c532-448e-935e-102e981cf698SPL ID 55072852-c532-448e-935e-102e981cf698SPL set ID 3e2d3974-38b0-49d0-8020-f74107584724RxCUI 898362, 898367, 898372UNII 0J48LPH2TH, N1SN99T69TUPC 0305740229019, 0305740228012, 0305740227015
- Pharmacologic class
- Angiotensin Converting Enzyme Inhibitor; Thiazide Diuretic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400574022901followed by a unit qualifier and the quantityPackage 00574-0229-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Benazepril HCl and Hydrochlorothiazide is indicated for the treatment of hypertension. This fixed combination drug is not indicated for the initial therapy of hypertension (see DOSAGE AND ADMINISTRATION ) .
Excerpt only. Read the full label for complete information.
About NDC 0574-0229
- What is NDC 0574-0229?
- 0574-0229 is the product NDC for benazepril hydrochloride and hydrochlorothiazide, Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 12.5 mg/1 tablet, listed with the FDA by Padagis US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- benazepril hydrochloride and hydrochlorothiazide.
- What is the active ingredient?
- Benazepril hydrochloride, Hydrochlorothiazide.
- Who is the labeler?
- Padagis US LLC, NDC labeler code 0574. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for benazepril hydrochloride and hydrochlorothiazide?
- 17 other product NDCs are listed under this name. See all benazepril hydrochloride and hydrochlorothiazide NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other benazepril hydrochloride and hydrochlorothiazide products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 10 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Advagen Pharma Ltd | 72888-220 | 72888-0220-01 |
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Advagen Pharma Ltd | 72888-221 | 72888-0221-01 |
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 25 mg/1 | TabletOral | Advagen Pharma Ltd | 72888-222 | 72888-0222-01 |
| Benazepril Hydrochloride and Hydrochlorothiazide | Benazepril hydrochloride 5 mg/1; Hydrochlorothiazide 6.25 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | 62559-414 | 62559-0414-01 |
| Benazepril Hydrochloride and Hydrochlorothiazide | Benazepril hydrochloride 10 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | 62559-415 | 62559-0415-01 |
| Benazepril Hydrochloride and Hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | 62559-416 | 62559-0416-01 |
| Benazepril Hydrochloride and Hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 25 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | 62559-417 | 62559-0417-01 |
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 25 mg/1 | TabletOral | Padagis US LLC | 0574-0228 | 00574-0228-01 |
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Bryant Ranch Prepack | 72162-2328 | 72162-2328-01 |
| Benazepril Hydrochloride and Hydrochlorothiazide | Benazepril hydrochloride 5 mg/1; Hydrochlorothiazide 6.25 mg/1 | Tablet, Film coatedOral | Sandoz Inc | 0185-0236 | 00185-0236-01 |
All 18 benazepril hydrochloride and hydrochlorothiazide NDCs
Other NDCs under NDA 020033
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 25 mg/1 | TabletOral | Padagis US LLC | 0574-0228 |
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Bryant Ranch Prepack | 72162-2328 |
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 10 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Advagen Pharma Ltd | 72888-220 |
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Advagen Pharma Ltd | 72888-221 |
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 25 mg/1 | TabletOral | Advagen Pharma Ltd | 72888-222 |
| Lotensin HCTbenazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 10 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Validus Pharmaceuticals LLC | 30698-452 |
| Lotensin HCTbenazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Validus Pharmaceuticals LLC | 30698-453 |
| Lotensin HCTbenazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 25 mg/1 | TabletOral | Validus Pharmaceuticals LLC | 30698-454 |